Send mail to Author

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus : a randomized, placebo-controlled phase II AIO trial with serum biomarker program (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____    __   __   _    _      ___      ______   __   __  
 |__  //   \ \\/ // | |  | ||   / _ \\   /_____//  \ \\/ // 
   / //     \ ` //  | |/\| ||  | / \ ||  `____ `    \ ` //  
  / //__     | ||   |  /\  ||  | \_/ ||  /___//      | ||   
 /_____||    |_||   |_// \_||   \___//   `__ `       |_||   
 `-----`     `-`'   `-`   `-`   `---`    /_//        `-`'   
                                         `-`
 


Back to frontdoor view

OPUS4 Logo